Search results
Results from the WOW.Com Content Network
Primavera Capital Group (Primavera; Chinese: 春華資本集團; pinyin: Chūnhuá Zīběn Jítuán) is a Chinese investment firm with offices in Hong Kong, Beijing, Silicon Valley and Singapore. It is considered one of China's leading investment firms with notable investments in companies such as Alibaba , Ant Group , ByteDance , XPeng , Yum ...
Draft laws, regulations and rules and policy plans on the administration and supervision of food (including food additives and health food, the same below) safety, drugs (including traditional Chinese medicines and ethno-medicines, the same below), medical devices and cosmetics; formulate normative documents, and facilitate the establishment and implementation of the food safety responsibility ...
Education in Hong Kong; Foreign relations of Hong Kong; Government of Hong Kong; Hong Kong; Hong Kong Basic Law; Hong Kong Basic Law Article 23; Tung Chee-hwa; Talk:2008 Summer Olympics; Talk:A Chinese Ghost Story; Talk:Andy Lau; Talk:Antony Leung; Talk:Apple Daily; Talk:Bank for International Settlements; Talk:Bank of China Tower (Hong Kong ...
This changed with reforms to Hong Kong's healthcare system in the late 1980s. In October 1987, Governor David Wilson officially announced the government's intention to establish a new, semi-independent Hospital Authority , which would be administered by a new Hospital Services Department (HSD). [ 1 ]
This bureau was newly established under the re-organization of policy bureaux proposed by Carrie Lam, the fifth Chief Executive of Hong Kong, and was adopted by John Lee, the succeeding Chief Executive after Carrie Lam. [2] On 19 June 2022, the Central People's Government announced the appointment of Professor Lo Chung-mau, previously the Head ...
Biosensors International also licenses its proprietary drug-eluting stent technologies to other medical device companies and specialty stent providers, including Terumo, Devax, Inc., and Xtent, Inc. Biosensors International Group has a joint-venture in Hong Kong listed as Shandong Weigao to market and distribute coronary stents in China. [1]
This suggestion was welcomed by Hong Kong medical experts. [6] Deputy health director Leung Pak-yin became the first controller of the CHP on 1 April 2004. [7] The initial operations of the centre were supported by a HK$500 million donation from the Hong Kong Jockey Club. [8] The centre officially commenced operation on 1 June 2004. [9]
Caritas Medical Centre (Chinese: 明愛醫院; Cantonese Yale: Mìhng'oi Yīyún) is a Roman Catholic founded district general hospital in So Uk, Cheung Sha Wan, New Kowloon, Hong Kong. It is the largest hospital in Sham Shui Po District and co-managed by the Hospital Authority and Caritas Hong Kong .